Biotech

Flare Therapeutics Inks Pact with Roche to Develop Small Molecules Targeting Undrugged Transcription Factors in Oncology

Flare Therapeutics Inks Pact with Roche to Develop Small Molecules Targeting Undrugged Transcription Factors in Oncology

Shots: The alliance will discover small molecule therapeutics targeting undrugged...

Pheast Therapeutics Highlights Preclinical Data of PHST001 at SITC 2024

Pheast Therapeutics Highlights Preclinical Data of PHST001 at SITC 2024

Shots: Pheast Therapeutics highlighted new preclinical data of PHST001, an anti-CD...

Poseida Therapeutics to Feature Non-Clinical Data of P-KLKB1-101 for Treating Hereditary Angioedema at ACAAI 2024

Poseida Therapeutics to Feature Non-Clinical Data of P-KLKB1-101 for Treating Hereditary Angioedema at ACAAI 2024

Shots: Poseida will highlight non-clinical data of P-KLKB1-101, a liver-directed g...

Revalesio Reports Results from its Non-Clinical Study of RNS60 for Amyotrophic Lateral Sclerosis (ALS)

Revalesio Reports Results from its Non-Clinical Study of RNS60 for Amyotrophic Lateral Sclerosis (ALS)

Shots: Revalesio highlighted non-clinical results of RNS60 in the ALS mouse models...

Bayer Collaborates with MOMA Therapeutics for the Development of a Small Molecule Oncology Program

Bayer Collaborates with MOMA Therapeutics for the Development of a Small Molecule Oncology Program

Shots: Bayer and MOMA Therapeutics have signed an exclusive licensing agreement fo...

AstraZeneca Inks a Pact with CSPC Pharmaceutical Group to Advance a Lipid-Lowering Pre-Clinical Candidate

AstraZeneca Inks a Pact with CSPC Pharmaceutical Group to Advance a Lipid-Lowering Pre-Clinical Candidate

Shots: AZ has signed an exclusive licensing agreement with CSPC Pharmaceutical Gro...

Image